Triton American Energy Provides Shareholder Update on Twelve Well Pilot Program

Business Wire, Oct 9, 2006

Reports Well Number 30 and 35 Showing Strong Oil Saturation with Little to No Water

HOUSTON -- Triton American Energy Corp. (Pink Sheets:TRAE), provider of natural gas and crude oil, is pleased to report its subsidiary Triton American Well Service, LLC (TAWS) has sand pumped, cleaned and ran gamma ray neutrons with collar locator to show perforations on all twelve wells. These wells are: 1A, 2A, 3A, 5, 7, 10A, 11, 13, 29, 30, 34, 35.

Jet drilling has already commenced. Initial tests on well number 35 indicate well should have strong oil output. Well number 11 and 30 showing strong oil saturation. These wells are located on the Northeast corner of the Blackwell Lease.

Management has tested one zone on 10A as well as two zones on 2A. These wells were the first to be tested and are located south side of the field. Initial results indicate high water content. Management plans to return to these wells to put them on beam pump to extract oil and water mix once water injection well is completed.

For more information, please contact Investor Relations at 973-351-3868 for Stephen Taylor or visit our website at: www.tritonamericanenergycorp.com.

About Triton American Energy Corporation:

Triton American Energy is an independent crude oil and natural gas and oil exploration and production company based in Houston, Texas. The company's business plan is structured to take advantage of today's rising energy cost, while reducing as much financial risk as possible. Triton's niche or specialty are the small to moderate operations (usually 1-50 well projects). These wells can be worth hundreds of millions of dollars in revenue but require more hands-on attention than the major producers are willing to give.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Except for historical information, the forward-looking matters discussed in this news release are subject to certain risks and uncertainties which could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements including, but not limited to, the Company's liquidity and the ability to obtain financing, the timing of regulatory approvals, uncertainties related to corporate partners or third-parties, product liability, the dependence on third parties for manufacturing and marketing, patent risk, copyright risk, competition, and the early stage of products being marketed or under development, as well as other risks indicated from time to time in the Company's filings with the Securities and Exchange.